Juan Pablo Frias's most recent trade in Biomea Fusion Inc was a trade of 349 Common Stock done at an average price of $8.9 . Disclosure was reported to the exchange on May 31, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biomea Fusion Inc | Juan Pablo Frias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 8.94 per share. | 31 May 2024 | 349 | 349 | - | 8.9 | 3,121 | Common Stock |
| Biomea Fusion Inc | Juan Pablo Frias | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 111,090 | 111,090 | - | - | Stock Option (Right to Buy) |